WHO ICTRP trial
A Cohort Study Evaluating the Effect of SGLT2 Inhibitors on Urinary Sodium…
ChiCTR2500104785 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500104785 |
|---|---|
| Public title | A Cohort Study Evaluating the Effect of SGLT2 Inhibitors on Urinary Sodium Excretion and Urine Volume in Patients with Liver Cirrhosis, Ascites, and Type 2 Diabetes Mellitus |
| Scientific title | A Cohort Study Evaluating the Effect of SGLT2 Inhibitors on Urinary Sodium Excretion and Urine Volume in Patients with Liver Cirrhosis, Ascites, and Type 2 Diabetes Mellitus |
| Primary sponsor | Baoding People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Refractory Cirrhotic Ascites |
| Interventions | Interventin group:Empagliflozin 10mg oral Qd plus standard care;Control group :Standard care |
| Registration date | Jun 23, 2025 |
| Target size | Interventin group:11;Control group :11 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: